Red blood cell (RBC) transfusion is a cornerstone of modern medicine, and accurate extended RBC phenotyping plays a vital role in preventing alloimmunization and ensuring transfusion compatibility. For patients at high risk, establishing extended RBC phenotypes is essential to minimizing alloimmunization and enabling the timely provision of compatible blood. Join Dr. Sofia Lejon Crottet as she explains the clinical importance of extended blood typing and identifies patient populations at increased risk of RBC alloimmunization.
Tuesday
7:00 AM PT | 4:00 PM CET
In this webinar, participants will be able to:
- Explore clinical study data evaluating the performance of a new serology-based product line for extended RBC typing
- Compare the advantages and limitations of serological and molecular typing approaches
- Examine the value of extended pretransfusion blood typing through case studies
About the Presenter
Sofia Lejon Crottet, PhD
Head of the Swiss National Immunohematology Reference Laboratory,
Interregional Blood Transfusion SRC Ltd., Bern, Switzerland
Dr. Sofia Lejon Crottet is Head of the Swiss National Immunohematology Reference Laboratory. She holds an MSc in Molecular Biology and a PhD in Biochemistry. Since joining Swiss Transfusion SRC in Bern in 2009, she has specialized in molecular blood group diagnostics and immunohematology, progressing from postdoctoral researcher to laboratory head in 2016. She leads complex case investigations, oversees RBC serology and molecular diagnostics, and regularly lectures at national and international transfusion medicine meetings, including ISBT.
Register now!
Can't attend the live webinar? Sign up now and we'll give you access to the recorded webinar.
Required fields